Ezrin is required for adhesion and migration in invasive breast cancer

por Szeto, Alvin, Hoskin, Victoria, Elliott, Bruce E
Publicado 2013

Ezrin, more than a metastatic detERMinant?

por Hoskin, Victoria, Ghaffari, Abdi, Elliott, Bruce E.
Publicado 2019

A novel activating role of SRC and STAT3 on HGF transcription in human breast cancer cells

por Sam, Michelle R, Elliott, Bruce E, Mueller, Christopher R
Publicado 2007

Activated Stat5 levels do not increase with cell density in contrast to activated Stat3 levels in breast epithelial cell culture

por Cass, Jamaica D, Geletu, Mulu, SenGupta, Sandip, Elliott, Bruce E, Raptis, Leda
Publicado 2013

The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells

por Elliott, Bruce E, Meens, Jalna A, SenGupta, Sandip K, Louvard, Daniel, Arpin, Monique
Publicado 2005

Ezrin regulates focal adhesion and invadopodia dynamics by altering calpain activity to promote breast cancer cell invasion

por Hoskin, Victoria, Szeto, Alvin, Ghaffari, Abdi, Greer, Peter A., Côté, Graham P., Elliott, Bruce E.
Publicado 2015

Interleukin-4 Expressed By Neoplastic Cells Provokes an Anti-Metastatic Myeloid Immune Response

por Zhang, Connie S., Kim, Hyeyeon, Mullins, Graeme, Tyryshkin, Kathrin, LeBrun, David P., Elliott, Bruce E., Greer, Peter A.
Publicado 2015

Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells

por Mak, Hannah, Naba, Alexandra, Varma, Sonal, Schick, Colleen, Day, Andrew, SenGupta, Sandip K, Arpin, Monique, Elliott, Bruce E
Publicado 2012

A novel role for ezrin in breast cancer angio/lymphangiogenesis

por Ghaffari, Abdi, Hoskin, Victoria, Szeto, Alvin, Hum, Maaike, Liaghati, Navid, Nakatsu, Kanji, Madarnas, Yolanda, Sengupta, Sandip, Elliott, Bruce E
Publicado 2014

Dataset of STAT5A status in breast cancer

por Mukhopadhyay, Utpal K., Cass, Jamaica, Raptis, Leda, Craig, Andrew W., Bourdeau, Véronique, Varma, Sonal, Gupta, Sandip Sen, Elliott, Bruce E., Ferbeyre, Gerardo
Publicado 2016

Erratum to: “A novel role for ezrin in breast cancer angio/lymphangiogenesis”

por Ghaffari, Abdi, Hoskin, Victoria, Szeto, Alvin, Hum, Maaike, Liaghati, Navid, Nakatsu, Kanji, LeBrun, David, Madarnas, Yolanda, SenGupta, Sandip, Elliott, Bruce E
Publicado 2015

Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy–induced Metastasis

por Hoskin, Victoria, Ghaffari, Abdi, Laight, Brian J., SenGupta, Sandip, Madarnas, Yolanda, Nicol, Christopher J.B., Elliott, Bruce E., Varma, Sonal, Greer, Peter A.
Publicado 2022

Automated Quantitative Analysis of p53, Cyclin D1, Ki67 and pERK Expression in Breast Carcinoma Does Not Differ from Expert Pathologist Scoring and Correlates with Clinico-Patholog...

por Cass, Jamaica D., Varma, Sonal, Day, Andrew G., Sangrar, Waheed, Rajput, Ashish B., Raptis, Leda H., Squire, Jeremy, Madarnas, Yolanda, SenGupta, Sandip K., Elliott, Bruce E.
Publicado 2012

Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer

por Ghaffari, Abdi, Hoskin, Victoria, Turashvili, Gulisa, Varma, Sonal, Mewburn, Jeff, Mullins, Graeme, Greer, Peter A., Kiefer, Friedemann, Day, Andrew G., Madarnas, Yolanda, SenGupta, Sandip, Elliott, Bruce E.
Publicado 2019

Immunohistochemical Assessment of Expression of Centromere Protein—A (CENPA) in Human Invasive Breast Cancer

por Rajput, Ashish B., Hu, Nianping, Varma, Sonal, Chen, Chien-Hung, Ding, Keyue, Park, Paul C., Chapman, Judy-Anne W., SenGupta, Sandip K., Madarnas, Yolanda, Elliott, Bruce E., Feilotter, Harriet E.
Publicado 2011